APA (7th ed.) Citation

Jiajie Lu, Quanquan Zhang, Xiaoning Guo, Wei Liu, Chunyang Xu, Xiaowei Hu, . . . Hongru Zhao. (2021). Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jiajie Lu, Quanquan Zhang, Xiaoning Guo, Wei Liu, Chunyang Xu, Xiaowei Hu, Jianqiang Ni, Haifeng Lu, and Hongru Zhao. Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Jiajie Lu, et al. Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison. Frontiers Media S.A., 2021.